EPROSARTAN
eprosartan 600 mg tablet, 28
EPROSARTAN (5491B)
5491B
Manner of administration:Oral
Restriction
Indication: Adverse effects occurring with all of the base-priced drugs
Restriction
Indication: Drug interactions occurring with all of the base-priced drugs
Restriction
Indication: Drug interactions expected to occur with all of the base-priced drugs
Restriction
Indication: Transfer to a base-priced drug would cause patient confusion resulting in problems
with compliance
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 28 | # of repeats: 5 | DPMQ: $28.07 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Teveten | |||||